MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*”Architects”: Geriatrics, Gerontology, Geroscience, Longevity, Healthspan & Aging
Viome Life Sciences, Inc.
Organization & Developments: Viome
Parents
Viome Life Sciences, Inc.
Children
2022: Home screening test for oral or throat cancer has 90 per cent accuracy_New Scientist
2022: Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
2023: Viome scores $86.5M and launches gut test into CVS
Clinical trial data will be used to expand Viome's mRNA analysis and artificial intelligence platform for detecting early signs of cancer.
Identifies the microorganisms in an individual’s gut, analyzes their activity and, using machine learning, provides nutritional recommendations to avoid chronic disease.
Studying using its mRNA platform to develop therapeutics for Alzheimer's, metabolic diseases and mental health.
The Viome kit is sold as an annual plan—customers receive an at-home collection kit twice a year and send their stool sample to a lab for analysis.
Using technology licensed from the Los Alamos National Laboratory, Viome identifies and quantifies all microorganisms in the gut and analyzes their function
Jumps
*Key People: Viome
Finance & Acquisitions: Viome